Holmes Biopharma, Inc. (LMB) Earnings
|
Expand Research on LMB
| Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +67.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +12.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/13/20 |  |
Q220 | $0.37 | -$0.31 | +$0.68 | $135.2M | $120.5M | = |  | | Details |
6/15/20  |
|
Q120 | N/A | -$0.16 | N/A | N/A | $134.5M | = | N/A | N/A | |
| 5/15/19 | |
Q119 | -$0.28 | -$0.08 | -$0.20 | $134M | $129M | = | | | Details |
| 4/17/17 | |
Q417 | -$0.45 | -$0.07 | -$0.38 | $133.7M | $97M | = | | | Details |
| 5/14/21 | |
Q121 | -$0.25 | -$0.03 | -$0.22 | $113.3M | $122.15M | = | | | Details |
| 5/10/22 |
|
Q122 | N/A | -$0.03 | N/A | N/A | $114.37M | N/A | N/A | N/A | |
| 5/16/17 |
|
Q117 | N/A | N/A | N/A | N/A | $108.33M | = | N/A | N/A | |
| 11/19/18 | |
Q318 | -$0.46 | N/A | N/A | $135.06M | $140.77M | = | | | Details |
